“High drug prices were a hot topic of discussion at HHS secretary nominee Alex Azar’s Senate confirmation hearing Tuesday, reports USA Today.

Here are four things to know about Mr. Azar’s stance on drug prices:

1. He agrees drug prices are too high. Sen. Ron Wyden, D-Ore., cited numerous drugs that more than doubled in price while Mr. Azar served as a drug executive at Eli Lilly. When asked if he ever lowered prices on any drugs during his tenure at the company, Mr. Azar said, “Drug prices are too high. I said that when I was at Lilly.”

Read More: https://www.beckershospitalreview.com/supply-chain/hhs-nominee-alex-azar-grilled-on-drug-prices-during-senate-hearing-4-things-to-know.html

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields